Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines which were referred to the Minister of Health under the provisions of section 24(5) of the Act and are set out in the Schedule hereto:
Schedule
Product: Active Ingredient: Dosage Form: New Zealand Sponsor: Manufacturers:
|
Epilim 100 Crushable Sodium valproate 100mg Tablet sanofi-aventis new zealand limited Sanofi-Synthelabo Limited, Tyne & Wear, United Kingdom Sanofi India Limited, Goa, India
|
Product: Active Ingredient: Dosage Form: New Zealand Sponsor: Manufacturers:
|
Epilim EC Sodium valproate 200mg Modified release tablet sanofi-aventis new zealand limited Sanofi-Synthelabo Limited, Tyne & Wear, United Kingdom Sanofi India Limited, Goa, India
|
Product: Active Ingredient: Dosage Form: New Zealand Sponsor: Manufacturers:
|
Epilim EC Sodium valproate 500mg Modified release tablet sanofi-aventis new zealand limited Sanofi-Synthelabo Limited, Tyne & Wear, United Kingdom Sanofi India Limited, Goa, India
|
Product: Active Ingredients:
Dosage Form: New Zealand Sponsor: Manufacturers:
|
NeisVac-C Neisseria meningitidis Group C polysaccharide 10mcg Tetanus toxoid 10mcg Suspension for injection Baxter Healthcare Limited Baxter Pharmaceutical Solutions LLC, Indiana, United States of America Baxter AG, Vienna, Austria
|
Dated this 5th day of February 2015.
CHRIS JAMES, Acting Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).